Clovis Oncology, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
2.00
|
|
Average Rating
|
2.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
1
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.41
|
-0.39
|
0.02
|
4.88%
|
|
2022-06-30
|
-0.41
|
-0.50
|
-0.09
|
-21.95%
|
|
2022-03-31
|
-0.43
|
-0.44
|
-0.01
|
-2.33%
|
|
2021-12-31
|
-0.57
|
-0.48
|
0.09
|
15.79%
|
|
2021-09-30
|
-0.48
|
-0.56
|
-0.08
|
-16.67%
|
|
2021-06-30
|
-0.56
|
-0.61
|
-0.05
|
-8.93%
|
|
2021-03-31
|
-0.72
|
-0.64
|
0.08
|
11.11%
|
|
2020-12-31
|
-0.77
|
-1.02
|
-0.25
|
-32.47%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.33
|
|
2021-12-31
|
-2.29
|
|
2020-12-31
|
-4.45
|
|
2019-12-31
|
-7.43
|
|
2018-12-31
|
-7.07
|
|
2017-12-31
|
-7.49
|
|
2016-12-31
|
-9.07
|
|
2015-12-31
|
-9.70
|
|
2014-12-31
|
-4.73
|
|
2013-12-31
|
-2.92
|
|
2012-12-31
|
-2.99
|
|
2011-12-31
|
-1.97
|